Heme trafficking and its impact on systemic iron homeostasis
血红素运输及其对全身铁稳态的影响
基本信息
- 批准号:8004431
- 负责人:
- 金额:$ 39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-01 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AlbuminsBile fluidCell LineCellsChronicClinicalComplexDataDietDuodenumEquilibriumErythrocytesFeline Leukemia VirusGastrointestinal tract structureGoalsGrantHemeHeme IronHemochromatosisHemoglobinHemolysisHemopexinHepatocyteHomeostasisIn VitroInflammationIngestionIronKidneyKupffer CellsLiverMarrowModelingMusMutagenesisPersonsPhysiologicalProcessProductionRecyclingRegulationScienceSiteSkinStructureSubgroupTissuesTransferrinXenopus oocyteabsorptionelectron crystallographyextracellulargastrointestinalheme-binding proteinin vivoinsightmacrophagemetal transporting protein 1receptorsenescencetooltrafficking
项目摘要
DESCRIPTION (provided by applicant): The goal of this project is to study how heme trafficking might impact systemic iron homeostasis. As 25 mg of iron is required daily to maintain red cell production, only 1-2 mg/d is absorbed from the GI tract, and 1-2 mg/d is lost through sloughed gastrointestinal, skin and kidney mucosal cells, most iron is recycled. The traditional view is that when macrophages engulf senescent red cells, their hemoglobin is degraded to heme then iron, which is exported via ferroportin to transferrin for delivery to the liver (for storage) or to the marrow (for new red cell production). In previous studies, we determined that the feline leukemia virus-C receptor, FLVCR, specifically exports heme from cells (Cell 118:757-66, 2004). On western analysis, FLVCR is highly expressed in the duodenum, liver and macrophage, tissues critical for iron absorption and trafficking; and Flvcr-deleted mice have excess iron at these sites, in addition to red cell aplasia (Science 319:825-828, 2008). These observations, plus studies of cell lines and primary macrophages in vitro, led us to hypothesize that heme, not only iron, is trafficked. This grant will define FLVCR structure and discern the mechanism by which it exports heme to heme-binding proteins, such as hemopexin and albumin, using mutagenesis analyses, Xenopus oocytes studies, and electron crystallography. We will determine how iron regulates the intercellular localization of FLVCR to aid systemic iron balance. In addition, we will determine the fate of heme from red cells after the cells are ingested by macrophages by studying macrophages from Flvcrflox/flox;LysM-cre mice in vitro and in vivo; determine the fate of heme once delivered to liver by studying Flvcrflox/flox;alb-cre mice; determine if hepatocytes can secrete heme via FLVCR into the bile permitting iron to exit the body; and explore the implications of these findings in models of hemolysis, chronic inflammation, and hemochromatosis. Together these studies should demonstrate that the physiologic regulation of iron is more intricate and complex than previously appreciated.
PUBLIC HEALTH RELEVANCE: Systemic iron balance largely depends on macrophage iron recycling (20-25 mg/d in persons) and minimally on the ingestion of iron in the diet (1-2 mg/day). The current concept is that heme from red cells is converted to iron, then recycled to the marrow to make new red cells or transported to the liver for storage. Our data challenge this accepted paradigm; demonstrate that heme, and not only iron, is trafficked; and suggest that this trafficking could help regulate systemic iron balance and/or modify the clinical manifestations of hemolysis, chronic inflammation and hemochromatosis.
描述(由申请人提供):本项目的目标是研究血红素运输如何影响全身铁稳态。由于每天需要25毫克铁来维持红细胞的产生,只有1-2毫克/天从胃肠道吸收,1-2毫克/天通过脱落的胃肠道,皮肤和肾粘膜细胞损失,大多数铁被回收。传统观点认为,当巨噬细胞吞噬衰老的红细胞时,它们的血红蛋白被降解为血红素,然后是铁,铁通过膜铁转运蛋白输出为转铁蛋白,以输送到肝脏(用于储存)或骨髓(用于新的红细胞产生)。在先前的研究中,我们确定猫白血病病毒-C受体FLVCR特异性地从细胞输出血红素(Cell 118:757-66,2004)。在Western分析中,FLVCR在十二指肠、肝脏和巨噬细胞中高度表达,这些组织对于铁的吸收和运输至关重要;并且Flvcr缺失的小鼠除了红细胞再生障碍之外,在这些部位还具有过量的铁(Science 319:825-828,2008)。这些观察,加上体外细胞系和原代巨噬细胞的研究,使我们假设血红素,而不仅仅是铁,被贩运。这项资助将定义FLVCR结构,并利用诱变分析、爪蟾卵母细胞研究和电子晶体学来识别它将血红素输出为血红素结合蛋白(如血红素结合蛋白和白蛋白)的机制。我们将确定铁如何调节FLVCR的细胞间定位,以帮助全身铁平衡。此外,我们将通过在体外和体内研究来自Flvcrflox/flox;LysM-cre小鼠的巨噬细胞来确定红细胞被巨噬细胞摄取后来自红细胞的血红素的命运;通过研究Flvcrflox/flox;alb-cre小鼠来确定血红素一旦被递送到肝脏的命运;确定肝细胞是否可以经由FLVCR将血红素分泌到胆汁中,从而允许铁离开身体;并探讨这些发现在溶血、慢性炎症和血色病模型中的意义。总之,这些研究应该表明,铁的生理调节比以前认识到的更加错综复杂。
公共卫生相关性:全身铁平衡很大程度上取决于巨噬细胞铁再循环(20-25毫克/天的人)和最低限度的饮食中的铁摄入(1-2毫克/天)。目前的概念是,红细胞中的血红素转化为铁,然后再循环到骨髓中以制造新的红细胞或运输到肝脏中储存。我们的数据挑战了这种公认的范式;证明血红素,而不仅仅是铁,被贩运;并表明这种贩运可以帮助调节全身铁平衡和/或修改溶血,慢性炎症和血色素沉着症的临床表现。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Janis L Abkowitz其他文献
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial.
剂量调整后的 EPOCH 加 Inotuzumab Ozogamicin 用于治疗复发或难治性 B 细胞 ALL 成人患者:1 期剂量递增试验。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:28.4
- 作者:
N. E. Kopmar;Kim Quach;T. Gooley;C. Martino;S. Cherian;M. Percival;A. Halpern;C. Ghiuzeli;V. Oehler;Janis L Abkowitz;Roland B Walter;R. Cassaday - 通讯作者:
R. Cassaday
Structural and mechanistic insights into human choline and ethanolamine transport
对人类胆碱和乙醇胺运输的结构和机制的见解
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Keiken Ri;Tsai;Ainara Claveras Cabezudo;Wiebke Jösting;Zhang Yu;Andre Bazzone;Nancy C P Leong;Sonja Welsch;R. Doty;Gonca Gursu;Tiffany Jia Ying Lim;Sarah Luise Schmidt;Janis L Abkowitz;Gerhard Hummer;Di Wu;Long N. Nguyen;S. Safarian - 通讯作者:
S. Safarian
Janis L Abkowitz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Janis L Abkowitz', 18)}}的其他基金
Deciphering the molecular mechanism of ineffective erythropoiesis in MDS-5q
破译MDS-5q无效红细胞生成的分子机制
- 批准号:
10773217 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
遗传性骨髓衰竭和骨髓增生异常综合征的转化研究
- 批准号:
9144794 - 财政年份:2013
- 资助金额:
$ 39万 - 项目类别:
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
遗传性骨髓衰竭和骨髓增生异常综合征的转化研究
- 批准号:
9350172 - 财政年份:2013
- 资助金额:
$ 39万 - 项目类别:
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
遗传性骨髓衰竭和骨髓增生异常综合征的转化研究
- 批准号:
8583491 - 财政年份:2013
- 资助金额:
$ 39万 - 项目类别:
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
遗传性骨髓衰竭和骨髓增生异常综合征的转化研究
- 批准号:
8734906 - 财政年份:2013
- 资助金额:
$ 39万 - 项目类别:
Clinical and Molecular Characterization of Familial Marrow Failure Syndrome
家族性骨髓衰竭综合征的临床和分子特征
- 批准号:
8214798 - 财政年份:2012
- 资助金额:
$ 39万 - 项目类别:
Heme trafficking and its impact on systemic iron homeostasis
血红素运输及其对全身铁稳态的影响
- 批准号:
8257066 - 财政年份:2011
- 资助金额:
$ 39万 - 项目类别:
Heme trafficking and its impact on systemic iron homeostasis
血红素运输及其对全身铁稳态的影响
- 批准号:
8668043 - 财政年份:2011
- 资助金额:
$ 39万 - 项目类别:
Heme trafficking and its impact on systemic iron homeostasis
血红素运输及其对全身铁稳态的影响
- 批准号:
8541530 - 财政年份:2011
- 资助金额:
$ 39万 - 项目类别:
Heme trafficking and its impact on systemic iron homeostasis
血红素运输及其对全身铁稳态的影响
- 批准号:
8454539 - 财政年份:2011
- 资助金额:
$ 39万 - 项目类别: